Yoo Youngil, CEO of Dong Sung Pharmaceutical, claimed on November 19 that Kim Insoo, the joint administrator, pressured him regarding cooperation with the rehabilitation process and agreement to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback